COMP <GO>
ANIK vs TMCI // EV/EBITDA & P/E VALUATION
Anika Therapeutics Inc. (NASDAQ) VS. Treace Medical Concepts Inc. (NASDAQ) • 15-METRIC TALLY: ANIK 6
— TMCI 3
■ METRIC PARITY
LAST: $21.79 (+1.11%) • MKT CAP: $291.6M
valuation
—
LAST: $5.06 (+4.76%) • MKT CAP: $329.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIK VS. TMCI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANIK | TMCI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.60% | 79.80% | -23.20 | TMCI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | -32.40% | +22.20 | ANIK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.50% | -8.96% | +10.46 | ANIK | /fcf-yield <GO> |
| Operating Margin | -9.80% | -25.50% | +15.70 | ANIK | /operating-margins <GO> |
| Net Profit Margin | -9.80% | -27.70% | +17.90 | ANIK | /net-margins <GO> |
| Revenue Growth (YoY) | -5.90% | 1.60% | -7.50 | TMCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.90 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | ANIK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 51.6 | +1.53 | ANIK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $291.6M | $329.1M | -$37.5M | TMCI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANIK REV | TMCI REV | ANIK GROSS % | TMCI GROSS % | ANIK FCF | TMCI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $112.8M | $212.7M | 56.6% | 79.8% | $4.4M | -$29.5M |
| FY 2024 | $119.9M | $209.4M | 63.4% | 80.4% | -$2.3M | -$48.8M |
| FY 2023 | $120.8M | $187.1M | — | — | -$1.8M | -$34.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIK // BETA —
TMCI // BETA —